Company Filing History:
Years Active: 1996
Title: The Innovations of Stephen M French
Introduction
Stephen M French is an accomplished inventor based in Phoenixville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein interactions. His work has implications for understanding cellular processes and developing new therapeutic strategies.
Latest Patents
Stephen M French holds a patent for "Expression cloning of c-src SH3-domain binding proteins." This invention provides a unique SH3 binding domain core motif of the sequence RPLPXXP and cDNA clones encoding proteins that interact with the SH3 domain of c-src. Additionally, it elucidates the amino acid sequences that mediate this binding. Another embodiment of this invention is a method for identifying SH3-binding proteins and elucidating the sequences that mediate binding. This method may be used as an assay to select compounds that bind to this site and either inhibit or enhance the binding of the SH3 domain. He has 1 patent to his name.
Career Highlights
Stephen M French has worked at Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has contributed to various research initiatives. His expertise in protein interactions has been instrumental in advancing the company's research objectives.
Collaborations
Some of his notable coworkers include George H Searfoss, III, and Yuri D Ivashchenko. Their collaborative efforts have further enriched the research environment at Rhone-Poulenc Rorer Pharmaceuticals Inc.
Conclusion
Stephen M French's innovative work in the field of biotechnology highlights the importance of understanding protein interactions. His contributions continue to pave the way for advancements in therapeutic development.